Jump to Section
Need help with a legal contract?
What Is a Confidential Disclosure Agreement?
A confidential disclosure agreement (CDA) is a legal agreement between a minimum of two parties protecting proprietary information.
A confidential disclosure agreement protects a company’s project from being shared publicly. CDAs are most commonly used in companies and academic institutions that conduct clinical research.
Here is an article where you can learn more about confidential disclosure agreements.
What’s Included in a Confidential Disclosure Agreement?
A confidential disclosure agreement includes the following:
- A description of the project/research in question
- Limitations
- Restrictions
- Obligations to be upheld by all involved parties.
A confidentiality agreement or secrecy agreement may be used in research to restrict dissemination, which means limiting wider use.
They may also be used when two or more parties plan on collaborating; the confidential disclosure agreement will outline the nature of the potential relationship, the scope and extent of collaboration, and restrictions about what parties can and cannot discuss.
Here is an article that further explores confidential disclosure agreements in clinical research and academia.
What Is the Purpose of a Confidential Disclosure Agreement?
Also known as a nondisclosure agreement (NDA), the purpose of a confidential disclosure agreement is to protect research and proprietary information for evaluation purposes.
Many research labs and companies may share insights about their methodologies and technologies during collaboration. However, they issue a legal agreement to ensure their process and “trade secrets” remain confidential.
Signing a CDA or NDA shows good faith between all parties. It demonstrates trustworthiness and a desire to protect other agencies' methods and inside practices.
You may use a CDA if:
- You have ideas that you want to protect from theft.
- You or your business have potentially patentable products or ideas you wish to protect.
- You are hiring outside consultants who will have temporary access to confidential information.
- You want to protect research data and other confidential information related to clinical research.
- You are collaborating with one or more parties on projects that are not yet made public.
It is important to clarify what counts as “confidential information” from a legal standpoint. First, any public data cannot be kept secret under a CDA. This primarily refers to public records, such as a company’s business address.
Furthermore, a CDA/NDA may not always protect the information, such as in the event of a court subpoena.
Here is an article by Brown University to better understand how a confidential disclosure agreement can protect confidential information.
Confidential Disclosure Agreements in Clinical Research
In clinical research settings, such as laboratories and universities, many research topics include personal information.
It is important to protect participants’ and researchers’ identities throughout the research process. A CDA protects everyone included in non-public research from being shared with the public or used by third-party organizations.
A confidential disclosure agreement is often a one-way agreement that prevents confidential information from being disseminated before publication. Examples include designs that could be potentially protected by a patent, technologies, methodologies, and inventions that belong to the researcher(s).
Most CDAs in clinical research establishes a primary investigator. This person is the main point of contact with whom any involved parties must speak. Under the agreement, they are not allowed to discuss any information related to the research with anyone other than the primary investigator.
Most confidential disclosure agreements in research last between 3 to 7 years. This ensures that no third parties can access any information, and the researchers can utilize any results of their work without the risk of dissemination.
Here is an article about how confidential agreements are used in research.
What Are the Benefits of a Confidential Disclosure Agreement?
The benefits of a confidential disclosure agreement are protection against public disclosure of confidential information.
The parties in the CDA may have access to private data, but they cannot share this information with any third parties.
A confidential disclosure or non-disclosure agreement safeguards an organization's intellectual and proprietary rights as well as the identity and data of any research participants.
The greatest benefit to researchers or companies that issue CDAs is the protection of any intellectual rights. This can include their in-house methodologies, best practices, technologies, and other confidential information.
In a confidentiality and noncompete agreement,parties must agree not to enter business with products or services that directly compete with the contract’s issuer. This can help preserve and protect a business’s profitability when doing partnerships or hiring consultants.
Another major benefit is the peace of mind that the issuer can receive by having potential collaboration partners sign an NDA/CDA. Their signature serves as a legal promise to not discuss, disclose, or disseminate any confidential information they have access to during their agreement.
Here is an article where you can learn why CDAs/NDAs are important.
Who Writes a Confidential Disclosure Agreement?
The issuer of the confidential disclosure agreement should draw the agreement. The CDA may be a modified template or drawn entirely from scratch.
It may be beneficial to consult an attorney before issuing a CDA/NDA. This can ensure that all the information you wish to protect is covered with the appropriate legal jargon. It can also prevent parties from exploiting any oversights or loopholes and breaching their secrecy agreement.
If you decide to write your confidential disclosure agreement, you will need to include:
- The definition of confidential information under your agreement.
- Exclusions of any confidential information.
- Obligations of the receiving parties.
- The time periods of the CDA.
- The nature of a relationship, if any, established by the CDA.
- A severability clause.
- An integration and amendment clause.
- A waiver clause.
A non-competition agreement can be added as a clause to a confidential information agreement. Under this clause, signing parties agree not to take any ideas from their collaboration and use them in a competitive business strategy.
You may struggle to fully capture the complete details of a CDA if you have no legal experience. While many research facilities already have CDA documents, you may find an agreement written by a lawyer to be the most beneficial.
Suppose you are asked to sign a CDA but are unclear or uncertain about the contents. In that case, it is best to speak with an attorney before signing anything.
While it is not a crime to break a CDA, there can be legal penalties in some situations. The extent of any legal and financial consequence will depend on the type of information and use after the breach.
For example, if someone steals an idea they acquired through a collaborative project, the idea's originator can sue them for theft.
Penalties for breaking a confidential disclosure agreement can include termination from a job, the immediate termination of a partnership or joint venture, monetary fines, compensation for legal fees, and the return of a stolen asset.
In some cases, such as a stolen idea, you may be required to cease and desist any business practices that use the idea and remove it from all public spaces.
Here is an article that contains a sample confidentiality agreement.
Confidential Disclosure Agreement vs. Non-Disclosure Agreement
A confidential disclosure agreement is the same as a non-disclosure agreement. There are many variations of both types of agreements, but they all serve the same purpose: to protect confidential information.
The biggest difference between an NDA and CDA lies in their common uses. For example, a non-disclosure agreement is more common in most business settings.
A CDA is more common as a confidentiality agreement in clinical research.
In both cases, you may also see an integrated or separate noncompete agreement to protect a party’s intellectual rights. This type of clause is sometimes referred to as “restrictive covenants.”
Ultimately, a CDA and NDA are the same legal agreement. The term you choose can be a matter of personal preference, but it may also reflect the common name used in your line of work.
Here is an article to understand the difference between a CDA vs. NDA.
Post a project in ContractsCounsel’s marketplace to receive flat fee bids from lawyers for your project. All lawyers have been vetted by our team and peer-reviewed by our customers for you to explore before hiring.
Meet some of our Confidential Disclosure Agreement Lawyers
Michael M.
I am an experienced contracts professional having practiced nearly 3 decades in the area of corporate law and nearly a decade in the investment and finance arena. I enjoy providing a cost effective, high quality and timely solution to client needs. This includes any form of contract a business may encounter, start-up matters, financings, informal dispute resolution, as well as mergers and acquisitions. I graduated from NYU Law School. I have worked at top Wall Street firms, top regional firms as well as long term experience in my own practice. I would welcome the opportunity to be of service to you as a trusted fiduciary.
Mark F.
International-savvy technology lawyer with 35years+ in Silicon Valley, Tokyo, Research Triangle, Silicon Forest. Outside & inside general counsel, legal infrastructure development, product exports, and domestic & international contracts for clients across North America, Europe, and Asia. Work with Founders to establish startup and continuous revenue, sourcing and partnering with investors to attract funding, define success strategy and direct high-performing teams, advising stakeholders and Boards of Directors to steer company growth.
September 4, 2022
Alex P.
Managing partner at Patel & Almeida and has over 22 years of experience assisting clients in the areas of intellectual property. business, employment, and nonprofit law.
September 8, 2022
Tiffanie W.
Tiffanie Wilson is a business transactions and personal injury lawyer. She helps clients realize their business goals by expertly drafting contracts, providing sound legal advice, and working for justice for injured clients.
September 6, 2022
Daniel F.
An experienced attorney with a varied range of legal abilities. Focusing on real estate transactions and general commercial litigation.
September 7, 2022
Doug F.
Doug has over 20 years of private and public company general counsel experience focusing his legal practice on commercial transactions including both software and biotech. He is a tech savvy, business savvy lawyer who is responsive and will attain relationship building outcomes with your counterparty while effectively managing key risks and accelerating revenue. He received his Juris Doctor from Boston University School of Law earning the Book Award in Professional Ethics and after graduation he taught legal writing there for a number of years. Prior to law school, Doug earned a M.A in Mathematics at the State University of New York at Stony Brook, and a B.S in Honors Mathematics at Purdue University. After law school, Doug joined Fish & Richardson, where his practice focused on licensing software, trademarks and biotech. While at Fish & Richardson Doug authored a book on software licensing published by the American Intellectual Property Lawyers Association. Later he joined as General Counsel at FTP Software and led an IPO as well as corporate development. Doug has broad experience with a broad range of commercial agreement drafting and negotiation including SaaS software and professional services, distribution and other channel agreements, joint venture and M&A. Doug continued his leadership, corporate governance and commercial transaction practice at Mercury Computers (NASDAQ:MRCY) leading corporate development. Doug’s experience ranges from enterprise software to biotech and other vertical markets. He joined the board of Deque Systems in 2009 and joined in an operating role as President in 2020 successfully scaling the software business.
September 13, 2022
Kathryn K.
I graduated from Georgetown Law in 2009 and have been practicing for thirteen years. My primary practice areas are business law and commercial contracts, with a particular focus on B2B contracts and customer-facing terms for online service companies, and advising consultancies on services agreements. I also provide a range of services to government contractors. Although I have represented numerous Fortune 500 companies and the Defense Department, my passion is advising startups and small businesses. Prior to opening my own practice, I worked for four years at one of the most prestigious law firms in the world, a boutique appellate litigation firm headed by a former White House chief of staff, the federal government, and one of the country's most renowned government contracts firms. I live in Boulder but represent clients nationwide.